SPY756.36−0.45%QQQ683.58−0.98%BTC/USD72,746.00−1.60%DIA524.84+0.08%GLD360.55−1.27%TLT80.85−0.09%

Regenxbio Inc

RGNXNASDAQ

Trade with Public

$8.47

0.7810.14%

Last update: Nov 12, 4:21 AM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Thu Nov 5th, before the market open

Conference Call: The most recent conference call started at 8:00 AM, 7 days ago

Click to view the webcast

Regenxbio (RGNX) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Regenxbio (RGNX) stock.

Analyst Consensus — 13 Analysts

12Buy

1Hold

# Analysts13

Latest Upgrades and Downgrades for Regenxbio Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Mizuho	Graig Suvannavejh	Initiate	Outperform	$22
—	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$23→$21
—	Baird	Brian Skorney	PT Cut	Outperform	$32→$29
—	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$26→$23
—	Barclays	Eliana Merle	Downgrade	Overweight→Equal-Weight	$12
—	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$26
—	Baird	Brian Skorney	PT Raise	Outperform	$27→$32
—	Leerink Partners	Mani Foroohar	PT Raise	Outperform	$17→$18
—	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$30→$26
—	B of A Securities	Geoff Meacham	PT Cut	Buy	$25→$14
—	Barclays	Gena Wang	PT Cut	Overweight	$37→$12
—	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$32→$30
—	Morgan Stanley	Judah Frommer	PT Cut	Overweight	$18→$17
—	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$34→$32
—	Goldman Sachs	Paul Choi	PT Cut	Neutral	$14→$12
—	Morgan Stanley	Judah Frommer	PT Cut	Overweight	$25→$18
—	Chardan Capital	Daniil Gataulin	PT Cut	Buy	$52→$50
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$52
—	Stifel	Annabel Samimy	PT Raise	Buy	$40→$45
—	Leerink Partners	Mani Foroohar	PT Raise	Outperform	$16→$20

Regenxbio Inc

Regenxbio (RGNX) Stock Price Target 2026

Latest Upgrades and Downgrades for Regenxbio Stock

Regenxbio (RGNX) Stock Price Target 2026

Latest Upgrades and Downgrades for Regenxbio Stock

Analyst Ratings News

PRO
Mizuho Initiates Coverage On Regenxbio with Outperform Rating, Announces Price Target of $22

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $21

PRO
Baird Maintains Outperform on Regenxbio, Lowers Price Target to $29

This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $23

This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Mizuho Initiates Coverage On Regenxbio with Outperform Rating, Announces Price Target of $22

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $21

PRO
Baird Maintains Outperform on Regenxbio, Lowers Price Target to $29

This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $23

This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday

Regenxbio Inc

Regenxbio (RGNX) Stock Price Target 2026

Latest Upgrades and Downgrades for Regenxbio Stock

Regenxbio (RGNX) Stock Price Target 2026

Latest Upgrades and Downgrades for Regenxbio Stock

Analyst Ratings News

PROMizuho Initiates Coverage On Regenxbio with Outperform Rating, Announces Price Target of $22

PROHC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $21

PROBaird Maintains Outperform on Regenxbio, Lowers Price Target to $29

This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

PROHC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $23

This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday

People Also Watch

People Also Watch

Analyst Ratings News

PROMizuho Initiates Coverage On Regenxbio with Outperform Rating, Announces Price Target of $22

PROHC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $21

PROBaird Maintains Outperform on Regenxbio, Lowers Price Target to $29

This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

PROHC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $23

This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday

PRO
Mizuho Initiates Coverage On Regenxbio with Outperform Rating, Announces Price Target of $22

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $21

PRO
Baird Maintains Outperform on Regenxbio, Lowers Price Target to $29

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $23

PRO
Mizuho Initiates Coverage On Regenxbio with Outperform Rating, Announces Price Target of $22

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $21

PRO
Baird Maintains Outperform on Regenxbio, Lowers Price Target to $29

PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $23